Free Trial

SS Innovations International (SSII) Financials

SS Innovations International logo
$3.36 -0.17 (-4.82%)
Closing price 06/12/2026 04:00 PM Eastern
Extended Trading
$3.39 +0.03 (+0.89%)
As of 06/12/2026 07:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for SS Innovations International

Annual Income Statements for SS Innovations International

This table shows SS Innovations International's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-0.48 -1.04 -0.96 -3.39 -1.12 -1.48 -3.21 -21 -19 -12
Consolidated Net Income / (Loss)
-0.48 -1.04 -0.96 -3.39 -1.12 -1.48 -3.21 -21 -19 -12
Net Income / (Loss) Continuing Operations
-0.48 -1.04 -0.96 -3.39 -1.12 -1.48 -3.21 -21 -19 -12
Total Pre-Tax Income
-0.48 -1.04 -0.96 -3.39 -1.12 -1.48 -3.21 -21 -19 -8.16
Total Operating Income
-0.46 -1.01 -0.96 -3.37 -1.10 -1.41 -2.96 -20 -19 -8.19
Total Gross Profit
0.00 0.00 0.00 0.00 0.00 0.00 0.06 0.73 8.45 20
Total Revenue
0.00 0.00 0.00 0.00 0.00 0.00 1.44 5.88 21 42
Operating Revenue
- 0.00 0.00 0.00 0.00 0.00 1.44 5.88 21 42
Total Cost of Revenue
0.00 0.00 0.00 0.00 0.00 0.00 1.38 5.15 12 23
Operating Cost of Revenue
- - - - - - 1.38 5.15 12 23
Total Operating Expenses
0.46 1.01 0.96 3.37 1.10 1.41 3.02 21 27 28
Selling, General & Admin Expense
0.33 0.94 0.40 0.75 0.29 0.46 1.94 10 10 15
Research & Development Expense
0.13 0.07 0.03 0.06 0.00 0.00 0.99 1.06 2.49 3.69
Depreciation Expense
- - - - - - 0.10 0.15 0.44 1.08
Other Special Charges / (Income)
- - - - - - - 9.72 14 8.13
Total Other Income / (Expense), net
-0.02 -0.03 0.00 -0.02 -0.02 -0.08 -0.26 -0.60 -0.18 0.05
Interest Expense
0.02 0.03 0.00 0.02 0.00 0.00 0.27 0.89 0.97 1.11
Interest & Investment Income
0.00 0.00 0.00 0.00 -0.03 -0.08 - 0.29 0.80 1.14
Other Income / (Expense), net
- - - - - 0.00 0.01 - 0.00 0.02
Income Tax Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3.97
Basic Earnings per Share
($0.03) ($0.05) ($0.05) ($0.16) ($0.05) ($0.05) ($0.03) ($0.14) ($0.11) ($0.06)
Weighted Average Basic Shares Outstanding
18.51M 19.54M 20.86M 21.54M 23.37M 28.48M 128.16M 144.87M 170.85M 190.01M
Diluted Earnings per Share
($0.03) ($0.05) ($0.05) - - - ($0.03) ($0.14) ($0.11) ($0.06)
Weighted Average Diluted Shares Outstanding
18.51M 19.54M 20.86M 21.54M - - 128.16M 152.07M 181.20M 198.70M
Weighted Average Basic & Diluted Shares Outstanding
18.51M 19.54M 20.86M 21.54M - - 53.89M 170.72M - 194.36M

Quarterly Income Statements for SS Innovations International

This table shows SS Innovations International's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
-2.03 -12 -9.84 -4.14 -3.25 -1.92 -5.68 -0.26 -3.72 -2.47 -3.58
Consolidated Net Income / (Loss)
-1.90 -12 -9.84 -4.14 -3.25 -1.92 -5.68 -0.26 -3.72 -2.47 -3.58
Net Income / (Loss) Continuing Operations
-1.90 -12 -9.84 -4.14 -3.25 -1.92 -5.68 -0.26 -3.72 -2.47 -3.58
Total Pre-Tax Income
-1.90 -12 -9.84 -4.14 -3.25 -1.92 -5.68 0.10 -1.87 -0.71 -3.43
Total Operating Income
-1.85 -12 -9.83 -4.10 -3.20 -1.84 -5.92 0.10 -1.84 -0.53 -3.64
Total Gross Profit
0.30 -0.42 0.73 1.44 2.32 3.97 1.09 5.92 6.16 6.38 5.33
Total Revenue
4.37 -0.76 3.64 4.51 4.39 8.12 5.12 10 13 15 11
Operating Revenue
4.37 -0.76 3.64 4.51 4.39 8.12 5.12 10 13 15 11
Total Cost of Revenue
1.89 1.85 2.91 3.07 2.07 4.15 4.03 4.09 6.66 8.16 5.77
Operating Cost of Revenue
1.89 1.85 2.91 3.07 2.07 4.15 4.03 4.09 6.66 8.16 5.77
Total Operating Expenses
4.30 9.59 11 5.54 5.52 5.81 7.01 5.82 8.00 6.91 8.97
Selling, General & Admin Expense
1.80 1.73 2.84 2.24 2.51 2.56 3.41 3.43 4.82 3.19 4.50
Research & Development Expense
0.29 0.28 0.53 0.76 0.44 0.76 1.01 0.50 0.79 1.39 1.00
Depreciation Expense
0.04 0.05 0.08 0.09 0.12 0.15 0.21 0.26 0.30 0.31 0.32
Other Special Charges / (Income)
0.02 9.69 7.11 2.44 2.45 2.34 2.38 1.63 2.10 2.02 3.14
Total Other Income / (Expense), net
-0.09 0.06 -0.01 -0.04 -0.04 -0.08 0.24 0.00 -0.04 -0.15 0.21
Interest Expense
0.13 0.14 0.19 0.24 0.25 0.29 0.38 0.22 0.18 0.34 0.28
Interest & Investment Income
0.09 - 0.18 0.20 0.21 0.21 0.62 0.22 0.14 0.16 0.49
Income Tax Expense
0.00 - 0.00 0.00 0.00 - 0.00 0.35 1.85 1.77 0.15
Basic Earnings per Share
($0.01) ($0.08) ($0.06) ($0.02) ($0.02) ($0.01) ($0.03) $0.00 ($0.02) ($0.01) ($0.02)
Weighted Average Basic Shares Outstanding
147.71M 144.87M 170.73M 170.74M 170.78M 170.85M 178.84M 193.57M 193.59M 190.01M 196.01M
Diluted Earnings per Share
($0.01) ($0.08) ($0.06) ($0.02) ($0.02) ($0.01) ($0.03) $0.00 ($0.02) ($0.01) ($0.02)
Weighted Average Diluted Shares Outstanding
147.84M 152.07M 181.61M 181.84M 181.89M 181.20M 188.60M 202.84M 202.86M 198.70M 205.31M
Weighted Average Basic & Diluted Shares Outstanding
169.63M 170.72M 170.74M 170.74M 170.86M 0.00 193.60M 193.59M 193.62M 194.36M 200.13M

Annual Cash Flow Statements for SS Innovations International

This table details how cash moves in and out of SS Innovations International's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
0.25 0.20 -0.42 -0.01 0.13 0.25 0.14 6.98 -0.74 3.96
Net Cash From Operating Activities
-0.21 -0.45 -0.44 -0.42 -0.09 -0.36 -5.99 -15 -9.50 -19
Net Cash From Continuing Operating Activities
-0.21 -0.71 -0.44 -0.42 -0.09 -0.36 -5.99 -15 -9.50 -19
Net Income / (Loss) Continuing Operations
-0.48 -1.04 -0.96 -3.39 -1.12 -1.48 -3.21 -21 -19 -12
Consolidated Net Income / (Loss)
-0.48 -1.04 -0.96 -3.39 -1.12 -1.48 -3.21 -21 -19 -12
Depreciation Expense
0.00 0.00 0.02 0.04 0.04 0.02 0.10 0.15 0.44 1.08
Non-Cash Adjustments To Reconcile Net Income
0.13 0.27 0.58 2.53 0.45 1.95 0.29 15 15 8.02
Changes in Operating Assets and Liabilities, net
0.14 0.06 -0.08 0.37 0.54 -0.85 -3.16 -9.66 -6.08 -16
Net Cash From Investing Activities
-0.04 -0.00 -0.02 -0.05 -0.04 0.04 0.24 -0.45 -0.66 -3.66
Net Cash From Continuing Investing Activities
-0.04 -0.00 -0.02 -0.05 -0.04 0.04 0.24 -0.45 -0.66 -3.66
Purchase of Property, Plant & Equipment
0.00 -0.00 -0.01 -0.05 -0.00 - 0.24 -0.45 -0.66 -3.66
Net Cash From Financing Activities
0.50 0.66 0.05 0.47 0.27 0.57 5.90 23 9.43 26
Net Cash From Continuing Financing Activities
0.50 0.66 0.05 0.47 0.27 0.57 5.90 23 9.43 26
Repayment of Debt
- -0.02 - - - 0.00 2.90 2.35 1.98 -1.83
Issuance of Debt
0.48 0.00 0.03 0.43 0.07 0.00 3.00 20 7.45 28

Quarterly Cash Flow Statements for SS Innovations International

This table details how cash moves in and out of SS Innovations International's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
11 -4.37 -0.16 -0.48 -0.12 0.02 15 -4.47 -5.13 -1.86 16
Net Cash From Operating Activities
-5.59 -4.39 -2.67 -1.02 -2.55 -3.26 -6.10 -3.45 -7.47 -1.52 -2.31
Net Cash From Continuing Operating Activities
-5.59 -4.39 -2.67 -1.02 -2.55 -3.26 -6.10 -3.40 -7.47 -1.52 -2.32
Net Income / (Loss) Continuing Operations
-1.90 -12 -9.84 -4.14 -3.25 -1.92 -5.68 -0.26 -3.72 -2.47 -3.58
Consolidated Net Income / (Loss)
-1.90 -12 -9.84 -4.14 -3.25 -1.92 -5.68 -0.26 -3.72 -2.47 -3.58
Depreciation Expense
0.04 0.05 0.08 0.09 0.12 0.15 0.21 0.26 0.30 0.31 0.32
Non-Cash Adjustments To Reconcile Net Income
-0.15 9.88 7.62 2.85 2.39 2.43 2.18 1.70 2.57 1.78 3.00
Changes in Operating Assets and Liabilities, net
-3.58 -2.18 -0.53 0.18 -1.81 -3.92 -2.81 -5.11 -6.61 -1.13 -2.06
Net Cash From Investing Activities
-0.22 -0.13 -0.13 -2.11 1.70 -0.13 -0.87 -0.32 -0.76 -1.71 -0.05
Net Cash From Continuing Investing Activities
-0.22 -0.13 -0.13 -2.11 1.70 -0.13 -0.87 -0.32 -0.76 -1.71 -0.05
Purchase of Property, Plant & Equipment
-0.22 -0.13 -0.13 -2.11 1.70 -0.13 -0.87 -0.32 -0.76 -1.71 -0.05
Net Cash From Financing Activities
17 0.15 2.64 2.65 0.72 3.41 22 -0.70 3.09 1.37 18
Net Cash From Continuing Financing Activities
17 0.15 2.64 2.65 0.72 3.41 22 -0.70 3.09 1.37 18
Repayment of Debt
2.76 -0.26 0.19 0.65 0.22 0.91 -5.59 -0.70 3.09 1.37 0.00
Issuance of Debt
14 - 2.45 2.00 0.50 2.50 28 - - - -0.29
Other Financing Activities, net
- 0.41 - - - - - - - - 18

Annual Balance Sheets for SS Innovations International

This table presents SS Innovations International's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
0.29 0.51 0.15 0.13 0.32 0.43 6.98 32 42 74
Total Current Assets
0.25 0.46 0.04 0.03 0.16 0.41 4.10 21 27 49
Cash & Equivalents
0.25 0.45 0.04 0.03 0.16 0.41 0.22 2.02 0.47 3.21
Restricted Cash
- - - - - - 0.06 5.03 5.84 5.94
Accounts Receivable
- - - - - 0.00 5.04 1.90 4.47 12
Inventories, net
- - - - - - 0.90 7.02 10 17
Prepaid Expenses
0.00 0.01 0.01 0.01 0.00 0.00 1.13 5.46 6.44 14
Plant, Property, & Equipment, net
0.00 0.00 0.04 0.08 0.04 0.02 0.42 0.71 5.39 9.10
Total Noncurrent Assets
0.04 0.04 0.07 0.01 0.12 0.00 2.47 9.38 9.58 12
Noncurrent Note & Lease Receivables
- - - - - - 0.89 2.37 3.30 8.57
Noncurrent Deferred & Refundable Income Taxes
- - - - - - - - 0.00 0.53
Other Noncurrent Operating Assets
- - - 0.00 0.12 - 1.58 7.02 6.28 3.21
Total Liabilities & Shareholders' Equity
0.29 0.51 0.15 0.13 0.32 0.43 6.98 32 42 74
Total Liabilities
0.65 0.41 0.37 1.20 1.19 0.29 9.66 12 29 36
Total Current Liabilities
0.65 0.41 0.37 1.20 1.19 0.29 7.77 8.47 21 26
Accounts Payable
0.05 0.01 0.03 0.51 0.33 0.12 0.17 0.90 2.31 5.13
Accrued Expenses
0.09 0.12 0.33 0.60 0.86 0.02 0.50 0.49 1.88 5.83
Current Deferred Revenue
- - - - - - 0.00 0.16 1.28 3.27
Other Current Liabilities
0.02 0.28 - - - - 3.30 6.42 8.40 12
Total Noncurrent Liabilities
0.00 0.00 0.00 0.00 0.00 0.00 1.89 3.32 7.60 9.77
Capital Lease Obligations
- - - - - - - 2.35 2.35 2.34
Noncurrent Deferred Revenue
- - - - - - 0.04 0.94 5.17 7.14
Other Noncurrent Operating Liabilities
- - - - - - 1.38 0.03 0.07 0.29
Commitments & Contingencies
- - 0.00 - 0.00 0.00 - - 0.00 0.00
Total Equity & Noncontrolling Interests
-0.36 0.10 -0.22 -1.06 -0.87 0.14 -2.68 20 13 38
Total Preferred & Common Equity
-0.36 0.10 -0.22 -1.06 -0.87 0.14 -2.68 20 13 38
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
-0.36 0.10 -0.22 -1.06 -0.87 0.14 -2.68 20 13 38
Common Stock
0.13 1.62 2.26 4.81 6.12 8.19 0.00 44 57 95
Retained Earnings
-0.49 -1.52 -2.48 -5.87 -6.99 -8.48 -3.63 -25 -44 -56
Accumulated Other Comprehensive Income / (Loss)
- - - - - - 0.05 -0.20 -0.75 -2.02
Other Equity Adjustments
- 0.00 - - - 0.46 0.90 0.90 0.90 0.90

Quarterly Balance Sheets for SS Innovations International

This table presents SS Innovations International's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets
1.65 5.47 12 28 35 36 39 63 70 70 91
Total Current Assets
1.64 5.46 7.65 23 24 23 25 48 51 48 66
Cash & Equivalents
0.51 0.45 0.42 6.60 0.95 0.61 0.22 16 11 5.68 16
Restricted Cash
- - 0.04 5.01 5.62 5.62 5.56 5.89 5.88 6.02 7.63
Accounts Receivable
1.10 5.00 1.34 7.17 6.48 5.57 5.14 3.96 5.97 6.92 14
Inventories, net
- - 3.97 5.10 6.92 7.22 9.42 14 18 20 17
Prepaid Expenses
0.02 0.01 1.88 2.30 3.63 4.26 4.74 7.60 9.29 9.77 16
Plant, Property, & Equipment, net
0.01 0.01 0.46 0.64 2.18 2.77 3.80 7.04 8.27 8.25 8.83
Total Noncurrent Assets
0.00 0.00 4.33 4.80 9.43 9.62 10 8.79 11 13 11
Noncurrent Note & Lease Receivables
- - 1.51 1.78 2.49 3.05 - 2.82 4.45 6.92 7.27
Noncurrent Deferred & Refundable Income Taxes
- - - - - - - - 0.37 0.16 0.81
Other Noncurrent Operating Assets
0.00 - 2.81 3.02 6.95 6.58 6.71 5.97 6.10 5.82 2.89
Total Liabilities & Shareholders' Equity
1.65 5.47 12 28 35 36 39 63 70 70 91
Total Liabilities
1.32 5.12 11 12 18 21 25 23 28 30 36
Total Current Liabilities
1.32 5.12 8.03 8.50 13 15 18 15 20 21 26
Accounts Payable
0.07 - 0.73 0.72 1.83 1.13 1.80 3.64 6.08 4.66 4.40
Accrued Expenses
0.01 0.01 0.82 0.70 1.36 1.18 1.91 1.43 3.78 3.61 6.33
Current Deferred Revenue
- - 0.04 0.09 0.25 0.40 2.30 1.87 2.41 2.51 3.58
Other Current Liabilities
- - 5.22 6.49 6.62 7.29 7.53 8.05 7.33 10 12
Total Noncurrent Liabilities
0.00 0.00 3.28 3.29 5.42 5.92 6.83 7.91 8.34 8.74 9.98
Capital Lease Obligations
- - - - 2.24 - 2.48 2.40 2.45 2.27 2.09
Noncurrent Deferred Revenue
- - 0.35 0.80 3.13 3.73 4.30 5.41 5.78 6.28 7.50
Other Noncurrent Operating Liabilities
- - 2.44 2.49 0.05 2.18 0.06 0.10 0.11 0.19 0.39
Commitments & Contingencies
0.00 0.00 - - - - - - 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
0.33 0.35 1.12 16 17 15 14 41 42 40 55
Total Preferred & Common Equity
0.33 0.35 1.12 16 17 15 14 41 42 40 55
Preferred Stock
0.00 - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
0.33 0.35 1.12 16 17 15 14 41 42 40 55
Common Stock
9.39 13 11 28 50 53 55 90 92 93 117
Retained Earnings
-9.52 -13 -10 -12 -34 -38 -42 -49 -50 -53 -59
Accumulated Other Comprehensive Income / (Loss)
- - -0.01 -0.14 -0.27 -0.28 -0.34 -0.73 -0.82 -1.30 -3.57
Other Equity Adjustments
0.46 - 0.90 0.90 0.90 0.90 0.90 0.90 0.90 0.90 0.90

Annual Metrics And Ratios for SS Innovations International

This table displays calculated financial ratios and metrics derived from SS Innovations International's official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
- - - - - - - - - 170,873,415.00
DEI Adjusted Shares Outstanding
- - - - - - - - - 170,873,415.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - -0.07
Growth Metrics
- - - - - - - - - -
Profitability Metrics
- - - - - - - - - -
Net Operating Profit after Tax (NOPAT)
-0.32 -0.71 -0.67 -2.36 -0.77 -0.98 -2.07 -14 -13 -5.74
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - -130.55% -62.85% -57.12% -14.14%
Earnings before Interest and Taxes (EBIT)
-0.46 -1.01 -0.96 -3.37 -1.10 -1.41 -2.95 -20 -19 -8.17
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-0.46 -1.01 -0.94 -3.31 -1.07 -1.39 -2.85 -20 -19 -7.10
Valuation Ratios
- - - - - - - - - -
Leverage & Solvency
- - - - - - - - - -
Liquidity Ratios
- - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -0.48 -0.78 -1.60 -0.74 -1.90 -5.13 -27 -15 -20
Efficiency Ratios
- - - - - - - - - -
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
-0.12 -0.35 -0.24 -1.00 -1.03 -0.12 2.94 16 17 31
Increase / (Decrease) in Invested Capital
0.00 -0.23 0.11 -0.76 -0.03 0.91 3.06 13 1.42 14
Book Value per Share
($0.02) $0.00 ($0.01) ($0.05) ($0.04) $0.01 ($0.06) $0.12 $0.08 $0.20
Tangible Book Value per Share
($0.02) $0.00 ($0.01) ($0.05) ($0.04) $0.01 ($0.06) $0.12 $0.08 $0.20
Total Capital
0.12 0.10 -0.21 -0.97 -0.87 0.29 1.59 23 23 41
Total Debt
0.48 0.00 0.02 0.09 0.00 0.15 4.26 2.86 9.80 2.34
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.47 2.35 2.35 2.34
Net Debt
0.23 -0.45 -0.02 0.06 -0.16 -0.26 3.99 -4.19 3.49 -6.81
Capital Expenditures (CapEx)
0.00 0.00 0.01 0.05 0.00 0.00 -0.24 0.45 0.66 3.66
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-0.17 -0.40 -0.35 -1.10 -1.18 -0.14 -0.15 6.41 7.23 13
Debt-free Net Working Capital (DFNWC)
0.08 0.05 -0.31 -1.07 -1.02 0.27 0.12 13 14 23
Net Working Capital (NWC)
-0.40 0.05 -0.33 -1.16 -1.02 0.12 -3.67 13 6.09 23
Net Nonoperating Expense (NNE)
0.16 0.33 0.29 1.03 0.35 0.50 1.14 6.69 5.87 6.39
Net Nonoperating Obligations (NNO)
0.23 -0.45 -0.02 0.06 -0.16 -0.26 5.62 -4.19 3.49 -6.81
Total Depreciation and Amortization (D&A)
0.00 0.00 0.02 0.05 0.04 0.02 0.10 0.15 0.44 1.08
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 ($0.05) ($0.05) ($0.16) ($0.05) ($0.05) ($0.05) $0.00 ($0.11) ($0.06)
Adjusted Weighted Average Basic Shares Outstanding
0.00 20.64M 20.86M 21.54M 23.37M 28.48M 40.88M 0.00 170.85M 190.01M
Adjusted Diluted Earnings per Share
$0.00 ($0.05) ($0.05) ($0.16) $0.00 $0.00 $0.00 $0.00 ($0.11) ($0.06)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 20.64M 20.86M 21.54M 0.00 0.00 53.89M 0.00 181.20M 198.70M
Adjusted Basic & Diluted Earnings per Share
$0.00 ($0.05) ($0.05) ($0.16) $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 19.54M 20.86M 21.54M 0.00 0.00 53.89M 0.00 0.00 194.36M
Normalized Net Operating Profit after Tax (NOPAT)
-0.32 -0.71 -0.67 -2.33 -0.77 -0.98 -2.07 -7.39 -3.24 -0.05
Debt Service Ratios
- - - - - - - - - -
Payout Ratios
- - - - - - - - - -

Quarterly Metrics And Ratios for SS Innovations International

This table displays calculated financial ratios and metrics derived from SS Innovations International's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
- - - - - - - - - 170,873,415.00 170,873,415.00
DEI Adjusted Shares Outstanding
- - - - - - - - - 170,873,415.00 170,873,415.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - -0.01 -0.02
Growth Metrics
- - - - - - - - - - -
Revenue Growth
726.30% -183.88% 882.84% 138.35% 0.29% 1,167.03% 40.77% 121.78% 192.47% - 116.80%
EBITDA Growth
-366.15% -614.14% -834.95% 22.24% -65.88% 86.03% 41.42% 108.91% 50.15% - 41.97%
EBIT Growth
-348.09% -606.57% -813.68% 21.02% -68.80% 84.88% 39.77% 102.37% 42.73% - 38.55%
NOPAT Growth
-335.38% -603.84% -818.37% 21.02% -73.03% 84.88% 39.77% 91.06% 42.73% - 38.55%
Net Income Growth
-290.34% -540.74% -649.55% 25.05% -70.95% 84.16% 42.27% 93.80% -14.56% - 36.94%
EPS Growth
0.00% -700.00% -500.00% 50.00% -100.00% 87.50% 50.00% 100.00% 0.00% - 33.33%
Operating Cash Flow Growth
0.00% -54.79% 49.73% 0.00% 0.00% 25.76% -128.43% -237.61% -193.22% - 62.12%
Free Cash Flow Firm Growth
-256.87% -230.10% -186.76% -126.06% 39.30% 86.08% 42.34% 0.61% -260.66% - -44.18%
Invested Capital Growth
719.68% 239.81% 207.06% 471.10% 36.59% 9.17% 37.73% 101.18% 153.78% - 55.68%
Revenue Q/Q Growth
131.21% -117.39% 0.00% 23.96% -2.72% 85.03% -36.91% 95.30% 28.29% - -23.62%
EBITDA Q/Q Growth
63.93% -551.28% 0.00% 58.11% 23.06% 45.13% -237.49% 106.26% -530.39% - -1,377.06%
EBIT Q/Q Growth
63.43% -540.50% 0.00% 57.52% 21.84% 42.63% -222.07% 101.64% -1,991.76% - -581.51%
NOPAT Q/Q Growth
64.32% -556.56% 0.00% 58.30% 21.84% 42.63% -222.07% 93.81% -400.60% - -581.51%
Net Income Q/Q Growth
65.63% -539.56% 0.00% 57.93% 21.62% 40.74% -195.38% 95.48% -1,348.42% - -44.96%
EPS Q/Q Growth
75.00% -700.00% 0.00% 66.67% 0.00% 50.00% -200.00% 100.00% 0.00% - -100.00%
Operating Cash Flow Q/Q Growth
0.00% 21.42% 0.00% 0.00% 0.00% -28.07% -87.12% 43.44% -116.31% - -52.14%
Free Cash Flow Firm Q/Q Growth
-44.22% -117.54% 0.00% 18.72% 61.27% 50.10% -267.12% -40.11% -40.52% - 3.27%
Invested Capital Q/Q Growth
268.00% 78.13% 0.00% -12.10% -11.98% 42.37% 25.05% 28.39% 11.03% - 5.05%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
6.83% 0.00% 20.02% 31.89% 52.83% 48.90% 21.23% 59.15% 48.05% - 47.99%
EBITDA Margin
-42.52% 0.00% -263.12% -88.92% -70.34% -20.86% -111.57% 3.57% -11.99% - -29.86%
Operating Margin
-42.34% 0.00% -270.29% -90.93% -73.06% -22.65% -115.65% 0.97% -14.31% - -32.78%
EBIT Margin
-43.41% 0.00% -265.32% -90.93% -73.06% -22.65% -115.65% 0.97% -14.31% - -32.78%
Profit (Net Income) Margin
-43.41% 0.00% -270.55% -91.83% -73.99% -23.70% -110.95% -2.57% -28.98% - -32.27%
Tax Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% -264.53% 198.73% - 104.41%
Interest Burden Percent
100.00% 99.85% 101.97% 100.98% 101.27% 104.61% 95.94% 100.02% 101.94% - 94.30%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 364.53% 0.00% - 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% 0.00% -20.16% -97.94% -3.48% -17.15% - -41.04%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% 162.55% -83.11% -3.48% 26.24% - -35.97%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 0.00% -3.41% 30.05% 0.98% -5.52% - 15.47%
Return on Equity (ROE)
0.00% 0.00% 0.00% 0.00% 0.00% -23.58% -67.90% -2.50% -22.67% - -25.57%
Cash Return on Invested Capital (CROIC)
0.00% -266.50% 0.00% 0.00% 0.00% -90.56% -89.39% -104.53% -118.50% - -58.82%
Operating Return on Assets (OROA)
0.00% 0.00% 0.00% 0.00% 0.00% -12.66% -51.89% 0.51% -9.50% - -20.63%
Return on Assets (ROA)
0.00% 0.00% 0.00% 0.00% 0.00% -13.24% -49.78% -1.34% -19.25% - -20.31%
Return on Common Equity (ROCE)
0.00% 0.00% 0.00% 0.00% 0.00% -23.58% -67.90% -2.50% -22.67% - -25.57%
Return on Equity Simple (ROE_SIMPLE)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -36.96% 0.00% 0.00% - 0.00%
Net Operating Profit after Tax (NOPAT)
-1.30 -8.51 -6.88 -2.87 -2.24 -1.29 -4.15 -0.26 -1.28 -0.37 -2.55
NOPAT Margin
-29.64% 0.00% -189.20% -63.65% -51.14% -15.86% -80.95% -2.57% -10.01% - -22.94%
Net Nonoperating Expense Percent (NNEP)
-17.40% 237.47% 179.00% 31,222.36% -21.24% -182.71% -14.83% 0.00% -43.39% - -5.07%
Return On Investment Capital (ROIC_SIMPLE)
-7.69% -37.70% -31.34% -14.53% -10.62% -5.53% -9.65% -0.58% -3.06% -0.92% -4.50%
Cost of Revenue to Revenue
43.17% 0.00% 79.98% 68.11% 47.17% 51.10% 78.77% 40.85% 51.95% - 52.01%
SG&A Expenses to Revenue
41.06% 0.00% 78.17% 49.78% 57.19% 31.55% 66.61% 34.29% 37.58% - 40.56%
R&D to Revenue
6.67% 0.00% 14.51% 16.83% 10.10% 9.39% 19.73% 4.99% 6.13% - 8.97%
Operating Expenses to Revenue
98.35% 0.00% 290.31% 122.82% 125.89% 71.56% 136.88% 58.18% 62.36% - 80.76%
Earnings before Interest and Taxes (EBIT)
-1.90 -12 -9.65 -4.10 -3.20 -1.84 -5.92 0.10 -1.84 -0.53 -3.64
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-1.86 -12 -9.57 -4.01 -3.09 -1.69 -5.71 0.36 -1.54 -0.22 -3.32
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.00 55.91 0.00 0.00 0.00 106.24 46.51 28.43 33.26 - 18.83
Price to Tangible Book Value (P/TBV)
0.00 55.91 0.00 0.00 0.00 106.24 46.51 28.43 33.26 - 18.83
Price to Revenue (P/Rev)
0.00 187.65 0.00 0.00 0.00 69.24 85.21 43.25 36.56 - 21.18
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 70.73 0.00 0.00 0.00 84.55 88.06 43.35 43.32 - 30.46
Enterprise Value to Revenue (EV/Rev)
0.00 186.94 0.00 0.00 0.00 69.41 84.34 42.71 36.30 - 20.74
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.03 0.15 0.31 0.34 0.54 0.73 0.06 0.06 0.06 - 0.04
Long-Term Debt to Equity
0.00 0.12 0.13 0.00 0.18 0.17 0.06 0.06 0.06 - 0.04
Financial Leverage
-0.41 0.18 0.19 0.00 -0.31 -0.02 -0.36 -0.28 -0.21 - -0.43
Leverage Ratio
1.78 2.26 2.38 3.03 2.23 2.23 1.72 1.86 2.04 - 1.62
Compound Leverage Factor
1.78 2.26 2.43 3.06 2.26 2.33 1.65 1.86 2.08 - 1.53
Debt to Total Capital
2.96% 12.67% 23.73% 25.23% 35.18% 42.14% 5.59% 5.51% 5.42% - 3.69%
Short-Term Debt to Total Capital
2.96% 2.26% 13.53% 25.23% 23.44% 32.03% 0.00% 0.00% 0.00% - 0.00%
Long-Term Debt to Total Capital
0.00% 10.41% 10.19% 0.00% 11.74% 10.10% 5.59% 5.51% 5.42% - 3.69%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Common Equity to Total Capital
97.04% 87.33% 76.27% 74.77% 64.82% 57.86% 94.41% 94.49% 94.58% - 96.31%
Debt to EBITDA
0.00 -0.14 0.00 0.00 0.00 -0.53 -0.17 -0.24 -0.26 - -0.44
Net Debt to EBITDA
0.00 0.21 0.00 0.00 0.00 -0.19 1.33 1.46 1.10 - 4.56
Long-Term Debt to EBITDA
0.00 -0.12 0.00 0.00 0.00 -0.13 -0.17 -0.24 -0.26 - -0.44
Debt to NOPAT
0.00 -0.20 0.00 0.00 0.00 -0.74 -0.23 -0.32 -0.34 - -0.50
Net Debt to NOPAT
0.00 0.30 0.00 0.00 0.00 -0.26 1.84 1.95 1.42 - 5.20
Long-Term Debt to NOPAT
0.00 -0.17 0.00 0.00 0.00 -0.18 -0.23 -0.32 -0.34 - -0.50
Altman Z-Score
0.00 54.39 0.00 0.00 0.00 28.73 48.98 25.58 26.26 - 17.12
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.67 2.53 1.81 1.55 1.36 1.29 3.18 2.59 2.29 - 2.54
Quick Ratio
1.62 0.46 0.57 0.41 0.29 0.23 1.32 0.88 0.59 - 1.15
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-8.95 -19 -17 -14 -5.43 -2.71 -9.95 -14 -20 -15 -14
Operating Cash Flow to CapEx
0.00% -3,452.86% -80.58% 0.00% 0.00% -2,606.45% -699.28% -1,090.27% -989.00% - -4,266.43%
Free Cash Flow to Firm to Interest Expense
-66.46 -141.00 -90.80 -57.83 -21.94 -9.25 -26.20 -64.32 -110.93 - -50.52
Operating Cash Flow to Interest Expense
0.00 -31.82 -6.57 0.00 0.00 -11.13 -16.07 -15.92 -42.28 - -8.14
Operating Cash Flow Less CapEx to Interest Expense
0.00 -32.74 -14.73 0.00 0.00 -11.56 -18.36 -17.38 -46.55 - -8.33
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.00 0.31 0.00 0.00 0.00 0.56 0.45 0.52 0.66 - 0.63
Accounts Receivable Turnover
0.00 1.69 0.00 0.00 0.00 6.49 4.24 4.79 5.98 - 5.38
Inventory Turnover
0.00 1.30 0.00 0.00 0.00 1.42 1.26 1.13 1.29 - 1.57
Fixed Asset Turnover
0.00 10.46 0.00 0.00 0.00 6.78 4.80 5.00 5.99 - 6.11
Accounts Payable Turnover
0.00 9.65 0.00 0.00 0.00 7.59 4.87 3.98 5.86 - 6.14
Days Sales Outstanding (DSO)
0.00 215.71 0.00 0.00 0.00 56.27 86.06 76.25 61.01 - 67.84
Days Inventory Outstanding (DIO)
0.00 280.74 0.00 0.00 0.00 257.73 290.68 324.36 284.01 - 231.89
Days Payable Outstanding (DPO)
0.00 37.81 0.00 0.00 0.00 48.09 74.93 91.74 62.24 - 59.48
Cash Conversion Cycle (CCC)
0.00 458.64 0.00 0.00 0.00 265.91 301.81 308.87 282.79 - 240.25
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
8.72 16 15 14 12 17 21 27 30 31 33
Invested Capital Turnover
0.00 0.58 0.00 0.00 0.00 1.27 1.21 1.36 1.71 - 1.79
Increase / (Decrease) in Invested Capital
7.65 11 10 11 3.19 1.42 5.81 14 18 14 12
Enterprise Value (EV)
0.00 1,098 0.00 0.00 0.00 1,433 1,867 1,180 1,309 - 1,005
Market Capitalization
0.00 1,103 0.00 0.00 0.00 1,430 1,886 1,195 1,319 - 1,027
Book Value per Share
$0.11 $0.12 $0.10 $0.09 $0.08 $0.08 $0.23 $0.22 $0.20 $0.20 $0.28
Tangible Book Value per Share
$0.11 $0.12 $0.10 $0.09 $0.08 $0.08 $0.23 $0.22 $0.20 $0.20 $0.28
Total Capital
17 23 22 20 21 23 43 44 42 41 57
Total Debt
0.50 2.86 5.21 4.98 7.43 9.80 2.40 2.45 2.27 2.34 2.09
Total Long-Term Debt
0.00 2.35 2.24 0.00 2.48 2.35 2.40 2.45 2.27 2.34 2.09
Net Debt
-11 -4.19 -1.36 -1.24 -1.78 3.49 -19 -15 -9.43 -6.81 -22
Capital Expenditures (CapEx)
0.00 0.13 1.55 0.00 0.00 0.13 0.87 0.32 0.76 1.71 0.05
Debt-free, Cash-free Net Working Capital (DFCFNWC)
3.11 6.41 6.96 7.05 5.75 7.23 11 14 16 13 17
Debt-free Net Working Capital (DFNWC)
15 13 14 13 12 14 33 31 27 23 40
Net Working Capital (NWC)
14 13 11 8.29 6.58 6.09 33 31 27 23 40
Net Nonoperating Expense (NNE)
0.60 3.63 2.96 1.27 1.00 0.64 1.54 0.00 2.43 2.10 1.04
Net Nonoperating Obligations (NNO)
-7.65 -4.19 -1.36 -1.24 -1.78 3.49 -19 -15 -9.43 -6.81 -22
Total Depreciation and Amortization (D&A)
0.04 0.05 0.08 0.09 0.12 0.15 0.21 0.26 0.30 0.31 0.32
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 109.16% 0.00% 0.00% 0.00% 35.02% 49.08% 50.38% 43.06% - 34.26%
Debt-free Net Working Capital to Revenue
0.00% 229.18% 0.00% 0.00% 0.00% 65.55% 147.40% 112.86% 75.52% - 82.98%
Net Working Capital to Revenue
0.00% 220.50% 0.00% 0.00% 0.00% 29.47% 147.40% 112.86% 75.52% - 82.98%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 ($0.08) ($0.06) ($0.02) ($0.02) ($0.01) ($0.03) $0.00 ($0.02) ($0.01) ($0.02)
Adjusted Weighted Average Basic Shares Outstanding
0.00 144.87M 170.73M 170.74M 170.78M 170.85M 178.84M 193.57M 193.59M 190.01M 196.01M
Adjusted Diluted Earnings per Share
$0.00 ($0.08) ($0.06) ($0.02) ($0.02) ($0.01) ($0.03) $0.00 ($0.02) ($0.01) ($0.02)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 152.07M 181.61M 181.84M 181.89M 181.20M 188.60M 202.84M 202.86M 198.70M 205.31M
Adjusted Basic & Diluted Earnings per Share
$0.00 ($0.08) $0.00 $0.00 $0.00 ($0.01) $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 170.72M 170.74M 170.74M 170.86M 0.00 193.60M 193.59M 193.62M 194.36M 200.13M
Normalized Net Operating Profit after Tax (NOPAT)
-1.28 -1.73 -1.91 -1.16 -0.53 0.35 -2.48 1.21 0.18 1.04 -0.35
Normalized NOPAT Margin
-29.25% 0.00% -52.41% -25.71% -12.02% 4.31% -48.43% 12.09% 1.42% - -3.12%
Pre Tax Income Margin
-43.41% 0.00% -270.55% -91.83% -73.99% -23.70% -110.95% 0.97% -14.58% - -30.91%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
-14.10 -88.06 -50.77 -16.90 -12.94 -6.28 -15.59 0.45 -10.39 - -12.81
NOPAT to Interest Expense
-9.63 -61.64 -36.21 -11.83 -9.06 -4.39 -10.91 -1.18 -7.27 - -8.97
EBIT Less CapEx to Interest Expense
0.00 -88.99 -58.93 0.00 0.00 -6.70 -17.89 -1.01 -14.66 - -13.00
NOPAT Less CapEx to Interest Expense
0.00 -62.57 -44.36 0.00 0.00 -4.82 -13.21 -2.64 -11.55 - -9.16
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%

Financials Breakdown Chart

Key Financial Trends

SS Innovations International (NASDAQ: SSII) showed a sharp top-line rebound in Q1 2026, but the quarter was still deeply unprofitable and cash burn remains a key issue. Revenue improved year over year, yet operating losses and negative operating cash flow continued.

  • Revenue growth resumed in Q1 2026. Operating revenue rose to $11.1 million, up from $5.1 million in Q1 2025 and above Q4 2025’s $14.5 million on a sequential basis, showing continued commercialization momentum.
  • Gross profit remained healthy. Q1 2026 gross profit was $5.3 million, with gross margin of about 48%, indicating the company is still generating meaningful profit before overhead and special charges.
  • Cash and equivalents increased materially. Cash and equivalents ended Q1 2026 at $16.0 million, up from $5.7 million in Q3 2025 and $15.9 million in Q1 2025, helped by financing inflows.
  • Net cash change was strongly positive in the quarter. SSII reported a $15.8 million increase in cash and equivalents, largely due to financing activity.
  • Debt appears reduced versus prior periods. The balance sheet shows no short-term debt in Q1 2026, while total liabilities rose mainly from operating obligations rather than large near-term borrowings.
  • Operating expenses remain elevated. SG&A was $4.5 million, R&D was $1.0 million, and depreciation was $0.3 million, so overhead still consumes most of the gross profit.
  • Special charges were significant. Q1 2026 included $3.1 million of other special charges, which materially pressured profitability and makes underlying earnings harder to judge.
  • Working capital is tied up in inventory and receivables. At quarter-end, inventories were $17.1 million and accounts receivable were $14.1 million, both sizable relative to revenue.
  • Deferred revenue provides some revenue visibility. Current deferred revenue was $3.6 million and noncurrent deferred revenue was $7.5 million, which may support future recognized revenue.
  • Net losses remain substantial. Q1 2026 net loss was $3.6 million, worse than the $2.5 million loss in Q4 2025 and still well below breakeven.
  • Operating cash flow was negative. SSII burned $2.3 million from operations in Q1 2026, meaning the business is not yet self-funding.
  • Losses worsened versus the prior quarter despite higher revenue. Revenue declined from Q4 2025, but operating income also swung back to a much larger loss, showing limited operating leverage so far.
  • Balance sheet leverage increased. Total liabilities reached $36.0 million versus $29.9 million in Q3 2025, while equity rose to $54.5 million; the company is still relying on external capital and financing support.

Bottom line: SSII is still in a high-growth, high-burn phase. The company is generating meaningful sales and gross profit, but recurring losses, negative operating cash flow, and large special charges mean investors should watch for continued revenue growth and, more importantly, improvement in operating discipline.

06/15/26 12:51 AM ETAI Generated. May Contain Errors.

SS Innovations International Financials - Frequently Asked Questions

According to the most recent income statement we have on file, SS Innovations International's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

SS Innovations International's net income appears to be on an upward trend, with a most recent value of -$12.13 million in 2025, rising from -$484.98 thousand in 2016. The previous period was -$19.15 million in 2024. See SS Innovations International's forecast for analyst expectations on what's next for the company.

SS Innovations International's total operating income in 2025 was -$8.19 million, based on the following breakdown:
  • Total Gross Profit: $19.54 million
  • Total Operating Expenses: $27.74 million

Over the last 9 years, SS Innovations International's total revenue changed from $0.00 in 2016 to $42.48 million in 2025, a change of 4,248,474,700.0%.

SS Innovations International's total liabilities were at $36.01 million at the end of 2025, a 24.5% increase from 2024, and a 5,462.9% increase since 2016.

In the past 9 years, SS Innovations International's cash and equivalents has ranged from $28.47 thousand in 2019 to $3.21 million in 2025, and is currently $3.21 million as of their latest financial filing in 2025.

Over the last 9 years, SS Innovations International's book value per share changed from -0.02 in 2016 to 0.20 in 2025, a change of -1,147.4%.



Financial statements for NASDAQ:SSII last updated on 5/17/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners